CTOs on the Move

BioSig Technologies

www.biosigtech.com

 
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.biosigtech.com
  • 8441 Wayzata Blvd Ste 240
    Minneapolis, MN USA 55426
  • Phone: 763.999.7330

Executives

Name Title Contact Details

Similar Companies

Ricerca Biosciences

Ricerca Biosciences is a Painesville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provant Health

Since day one, we`ve been dedicated to delivering personalized, innovative, and impactful workplace wellness programs. Provant is a health and wellness solutions company that partners with businesses to build cultures of health designed to improve the health, well-being, and productivity of employees while supporting employers with their healthcare affordability agenda. Provant`s Life+ Program combines personalized “high touch” services with powerful social networking tools that link rewards to healthy behaviors and outcomes. The results of these programs: exceptional engagement, improved health, productive employees, and lower costs. Founded in 2001, Provant serves customers of all sizes across the United States, Puerto Rico, Canada, and the Caribbean. Our customizable program is delivered to millions of people and consist of assessment services (e.g. screening services, flu vaccinations), inspirational services (e.g. coaching, lifestyle and condition programs) and reward and reporting services (participation-based and outcome-based programs). Program innovation, customization, and a comprehensive, quality approach to managing health risks are at the cornerstone of everything that we do. Our leadership team consists of seasoned wellness and business professionals with extensive experience in the health promotion, wellness, consumerism, medical, insurance, and hospital arenas. Our commitment to what we do is based on a sincere desire to promote wellness, to partner with our clients, and to work as a team. Improving lives in the process is what makes it all worthwhile.

Austin Medical Practice Management (AMPM)

Austin Medical Practice Management, Inc. (AMPM) is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Essilor Canada

Essilor Canada Ltd. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delphinus Medical Technologies

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.